NCT00427349 2023-07-05AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Completed46 enrolled 7 charts
NCT00574951 2018-01-11AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerGOG FoundationPhase 2 Terminated23 enrolled 9 charts
NCT00094835 2016-03-24Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)AmgenPhase 1/2 Completed51 enrolled 23 charts
NCT00101907 2014-03-20Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced CancerAmgenPhase 1 Terminated41 enrolled 17 charts